Browse
Submit Data
Databases
API
Help

Dataset Information

9 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Co(III) Complex of 1-Amino-4-hydroxy-9,10-anthraquinone Exhibits Apoptotic Action against MCF-7 Human Breast Cancer Cells.

ABSTRACT: A Co(III) complex of 1-amino-4-hydroxy-9,10-anthraquinone (QH) (Scheme-1) having the molecular formula CoQ₃ (Scheme-2) was prepared and characterized by elemental analysis, FTIR spectroscopy, UV-vis spectroscopy, fluorescence spectroscopy, and mass spectrometry. In the absence of a single crystal, the energy-optimized molecular structure of CoQ₃ was determined by employing computational methods that was validated using spectroscopic evidences, elemental analysis, and mass spectrometry data. The electrochemical properties of the complex were analyzed using cyclic voltammetry and indicate a substantial modification of the electrochemical properties of the parent amino-hydroxy-9,10-anthraquinone. CoQ₃ was thereafter tested on MCF-7 human breast cancer cells. The IC₅₀ value for a 24 h incubation was found to be (95 ± 0.05) μg/mL. The study showed that such cancer cells underwent both early and late apoptosis following the interaction with CoQ₃.

SUBMITTER: Banerjee S

PROVIDER: S-EPMC8756448 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

1-Dimethyl-amino-9,10-anthraquinone.

Project description:In the crystal structure of the title compound, C(16)H(13)NO(2), adjacent mol-ecules are linked through C-H⋯π and π-π [centroid-centroid distances = 3.844 (2) Å] contacts. The anthracene ring system and dimethyl-amino group are oriented at a dihedral angle of 38.4 (1)°. In the crystal, the mean planes of adjacent anthracene units are inclined at angles of 59.3 (1), 75.7 (1) and 76.0 (1)°.

| S-EPMC3052127 | biostudies-literature

2,6-Dimeth-oxy-9,10-anthraquinone.

Project description:The title compound, C(16)H(12)O(4), crystallizes with two half-mol-ecules in the asymmetric unit, each of which is completed by a crystallographic inversion center. The two crystallographically independent mol-ecules have almost the same geometry and are almost planar [maximum deviations = 0.018?(3) and 0.049?(3)?Å]. They adopt a conformation in which the C(meth-yl)-O bonds are directed along the mol-ecular short axis [C-C-O-C torsion angles of 179.6?(2) and 178.0?(2)°]. In the crystal, the mol-ecular packing is characterized by a combination of a columnar stacking and a herringbone-like arrangement. The mol-ecules form slipped ?-stacks along the b axis, in which there are two kinds of columns differing from each other in their slippage. The inter-planar distances between neighboring mol-ecules are 3.493?(3) for one column and 3.451?(2)?Å for the other.

| S-EPMC3470203 | biostudies-other

1,8-Bis(tos-yloxy)-9,10-anthraquinone.

Project description:In the crystal structure of the title compound, C(28)H(20)O(8)S(2), adjacent anthracene skeletons are parallel or inclined at an angle of 20.6?(1)°. In the mol-ecular structure, the mean plane of the anthracene skeleton makes dihedral angles of 49.6?(1) and 76.8?(1)° with the tosyl rings, and the two terminal benzene rings are oriented at an angle of 74.5?(1)° with respect to each other. The crystal structure is stabilized by inter-molecular C-H?O and C-O?? inter-actions.

| S-EPMC2980119 | biostudies-literature

1-(Piperidin-1-yl)-9,10-anthraquinone.

Project description:In the title compound, C(19)H(17)NO(2), the piperidine ring adopts a chair conformation. The mean planes of the piperidine ring and the anthracene ring system are inclined at a dihedral angle of 38.7?(1)°. In the crystal, adjacent mol-ecules are linked through C-H?? and ?-? [centroid-centroid distance = 3.782?(1)?Å] inter-actions, forming a layer parallel to the bc plane.

| S-EPMC3470233 | biostudies-literature

1,5-Diamino-2,6-dibromo-9,10-anthraquinone.

Project description:In the title compound, C(14)H(8)Br(2)N(2)O(2), the mol-ecular structure features intra-molecular N-H⋯O [2.639 (2) Å and 130°] and N-H⋯Br [3.053 (2) Å and 114°] hydrogen bonding. Due to inversion symmetry, the asymmetric part of the unit cell consits of one half-mol-ecule. In the crystal, inversion dimers linked by pairs of N-H⋯O [2.955 (2) Å and 135°] hydrogen bonds occur. The structure also features C=O⋯π [3.228 (2) Å] and Br⋯Br [3.569 (1) Å] contacts.

| S-EPMC3297896 | biostudies-literature

1-Meth-oxy-4-methyl-9,10-anthraquinone.

Project description:The non-H atoms of the title compound, C(16)H(12)O(3), lie approximately in a common plane (r.m.s. deviation = 0.032?Å). The methyl C atom is forced away from the carbonyl O atom which can be seen by the widened C(fused ring)-C(benzene)-C(meth-yl) angle of 125.8?(2)°.

| S-EPMC3247377 | biostudies-literature

1,8-Dihydr-oxy-2,4,5,7-tetra-nitro-9,10-anthraquinone.

Project description:The ring system in the title compound, C(14)H(4)N(4)O(12), is essentially planar (r.m.s. deviation of the carbon atoms = 0.085?Å); the two hydr-oxy groups form intra-molecular hydrogen bonds to the same carbonyl O atom. The nitro groups are twisted with respect to the mean plane of the ring system by 74.3?(1) (1-nitro), 42.3?(3) (3-nitro), 45.7?(3) (6-nitro) and 66.9?(1)° (8-nitro).

| S-EPMC2979082 | biostudies-other

2-(Dimethyl-amino)-anthraquinone.

Project description:The mol-ecule of the title compound, C(16)H(13)NO(2), is almost planar, with a maximum deviation of 0.013?(2)?Å from the best plane; the dihedral angle between the two aromatic rings is 1.06?(1)°. In the crystal, mol-ecules are linked through weak intra-molecular C-H?O inter-actions, forming chains running parallel to [10].

| S-EPMC3011451 | biostudies-literature

1,3-Dihydr-oxy-2-methoxy-methyl-9,10-anthraquinone from Rennellia elliptica Korth.

Project description:The title compound, C(16)H(12)O(5), common name: lucidin ?-methyl ether, exists as a planar mol-ecule (r.m.s. deviation = 0.04?Å). Within the mol-ecule, the 1-hydr-oxy group forms a hydrogen bond to the adjacent carbonyl O atom, and the 3-hydr-oxy group forms a hydrogen bond to the adjacent meth-oxy O atom. The meth-oxy O atom is disordered over two positions of equal occupancy.

| S-EPMC2969543 | biostudies-literature

1-Amino-4-hydroxy-9,10-anthraquinone - An analogue of anthracycline anticancer drugs, interacts with DNA and induces apoptosis in human MDA-MB-231 breast adinocarcinoma cells: Evaluation of structure-activity relationship using computational, spectroscopic and biochemical studies.

Project description:The X-ray diffraction and spectroscopic properties of 1-amino-4-hydroxy-9,10-anthraquinone (1-AHAQ), a simple analogue of anthracycline chemotherapeutic drugs were studied by adopting experimental and computational methods. The optimized geometrical parameters obtained from computational methods were compared with the results of X-ray diffraction analysis and the two were found to be in reasonably good agreement. X-ray diffraction study, Density Functional Theory (DFT) and natural bond orbital (NBO) analysis indicated two types of hydrogen bonds in the molecule. The IR spectra of 1-AHAQ were studied by Vibrational Energy Distribution Analysis (VEDA) using potential energy distribution (PED) analysis. The electronic spectra were studied by TDDFT computation and compared with the experimental results. Experimental and theoretical results corroborated each other to a fair extent. To understand the biological efficacy of 1-AHAQ, it was allowed to interact with calf thymus DNA and human breast adino-carcinoma cell MDA-MB-231. It was found that the molecule induces apoptosis in this adinocarcinoma cell, with little, if any, cytotoxic effect in HBL-100 normal breast epithelial cell.

| S-EPMC5669404 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data